📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones (2023)

First Author: Hasan A

Attributed to: Leveraging circulating tumour DNA (ctDNA) to dissect the evolutionary genomic dynamics of drug resistance in prostate cancer. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-40315-9

PubMed Identifier: 37563129

Publication URI: http://europepmc.org/abstract/MED/37563129

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1